Iridex (IRIX) Profit After Tax Growth (1y) (2011 - 2026)
Iridex (IRIX) Profit After Tax Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | -47.84% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 44.34% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 18.66% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 13.84% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -27.98% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 38.54% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 14.60% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 71.04% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 12.92% |
| 10 | Iridex | 13.40 Mn | 8.72 Mn | 4.30 Mn | -27.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 68.92% |
| Jan 3, 2026 | 77.94% |
| Sep 27, 2025 | 18.62% |
| Jun 28, 2025 | 62.90% |
| Mar 29, 2025 | 51.33% |
| Dec 28, 2024 | 71.82% |
| Sep 28, 2024 | -10.21% |
| Jun 29, 2024 | 3.15% |
| Mar 30, 2024 | -65.74% |
| Dec 30, 2023 | -157.84% |
| Sep 30, 2023 | 0.74% |
| Jul 1, 2023 | -23.43% |
| Apr 1, 2023 | 12.59% |
| Dec 31, 2022 | -224.11% |
| Oct 1, 2022 | 18.38% |
| Jul 2, 2022 | -260.88% |
| Apr 2, 2022 | -18.96% |
| Oct 2, 2021 | -25.95% |
| Jul 3, 2021 | 150.11% |
| Apr 3, 2021 | -21.74% |